BDBM50138237 3-[3-(4-Imidazol-1-yl-phenoxy)-propyl]-pyridine::CHEMBL262968

SMILES: C(COc1ccc(cc1)-n1ccnc1)Cc1cccnc1

InChI Key: InChIKey=GCRYIIOKZWQWIH-UHFFFAOYSA-N

Data: 5 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 5 hits for monomerid = 50138237   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Cytochrome P450 2D6 (Homo sapiens (Human))	BDBM50138237 (3-[3-(4-Imidazol-1-yl-phenoxy)-propyl]-pyridine | ...) Show SMILES C(COc1ccc(cc1)-n1ccnc1)Cc1cccnc1 Show InChI InChI=1S/C17H17N3O/c1-3-15(13-18-9-1)4-2-12-21-17-7-5-16(6-8-17)20-11-10-19-14-20/h1,3,5-11,13-14H,2,4,12H2	PDB UniProtKB/SwissProt UniProtKB/TrEMBL GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	1.30E+3	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co., Ltd Curated by ChEMBL					Assay Description Inhibition of cytochrome P450 2D6				Bioorg Med Chem Lett 14: 333-6 (2003) BindingDB Entry DOI: 10.7270/Q2JD4W74
					More data for this Ligand-Target Pair
Cytochrome P450 3A4 (Homo sapiens (Human))	BDBM50138237 (3-[3-(4-Imidazol-1-yl-phenoxy)-propyl]-pyridine | ...) Show SMILES C(COc1ccc(cc1)-n1ccnc1)Cc1cccnc1 Show InChI InChI=1S/C17H17N3O/c1-3-15(13-18-9-1)4-2-12-21-17-7-5-16(6-8-17)20-11-10-19-14-20/h1,3,5-11,13-14H,2,4,12H2	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	417	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co., Ltd Curated by ChEMBL					Assay Description Inhibition of cytochrome P450 3A4				Bioorg Med Chem Lett 14: 333-6 (2003) BindingDB Entry DOI: 10.7270/Q2JD4W74
					More data for this Ligand-Target Pair
Cytochrome P450 1A (Homo sapiens (Human))	BDBM50138237 (3-[3-(4-Imidazol-1-yl-phenoxy)-propyl]-pyridine | ...) Show SMILES C(COc1ccc(cc1)-n1ccnc1)Cc1cccnc1 Show InChI InChI=1S/C17H17N3O/c1-3-15(13-18-9-1)4-2-12-21-17-7-5-16(6-8-17)20-11-10-19-14-20/h1,3,5-11,13-14H,2,4,12H2	PDB MMDB Reactome pathway KEGG B.MOAD DrugBank GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	<46	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co., Ltd Curated by ChEMBL					Assay Description Inhibition of cytochrome P450 1A2				Bioorg Med Chem Lett 14: 333-6 (2003) BindingDB Entry DOI: 10.7270/Q2JD4W74
					More data for this Ligand-Target Pair
Cytochrome P450 2C19 (Homo sapiens (Human))	BDBM50138237 (3-[3-(4-Imidazol-1-yl-phenoxy)-propyl]-pyridine | ...) Show SMILES C(COc1ccc(cc1)-n1ccnc1)Cc1cccnc1 Show InChI InChI=1S/C17H17N3O/c1-3-15(13-18-9-1)4-2-12-21-17-7-5-16(6-8-17)20-11-10-19-14-20/h1,3,5-11,13-14H,2,4,12H2	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	<46	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co., Ltd Curated by ChEMBL					Assay Description Inhibition of cytochrome P450 2C19				Bioorg Med Chem Lett 14: 333-6 (2003) BindingDB Entry DOI: 10.7270/Q2JD4W74
					More data for this Ligand-Target Pair
Cytochrome P450 2C9 (Homo sapiens (Human))	BDBM50138237 (3-[3-(4-Imidazol-1-yl-phenoxy)-propyl]-pyridine | ...) Show SMILES C(COc1ccc(cc1)-n1ccnc1)Cc1cccnc1 Show InChI InChI=1S/C17H17N3O/c1-3-15(13-18-9-1)4-2-12-21-17-7-5-16(6-8-17)20-11-10-19-14-20/h1,3,5-11,13-14H,2,4,12H2	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	185	n/a	n/a	n/a	n/a	n/a	n/a
Taisho Pharmaceutical Co., Ltd Curated by ChEMBL					Assay Description Inhibition of cytochrome P450 2C9				Bioorg Med Chem Lett 14: 333-6 (2003) BindingDB Entry DOI: 10.7270/Q2JD4W74
					More data for this Ligand-Target Pair